在食道癌的新辅助化疗期间的久坐时间:探索性前性队列研究
Tsuyoshi Harada1,2, Tetsuya Tsuji3,2, Junya Ueno3
1Department of Rehabilitation Medicine, National Cancer Center-Hospital East, Kashiwa, Japan tsuyoshi6167@gmail.com.
BMJ supportive & palliative care
|December 18, 2025
概括
患有局部晚期食道癌 (LAEC) 的老年患者在新辅助化疗 (NAC) 期间体验了久坐时间的增加,主要是由于疲劳恶化. 在NAC期间的体力活动干预措施可能会改善这些患者的结果.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 身体活动研究 身体活动研究
背景情况:
- 新辅助化疗 (NAC) 是局部晚期食道癌 (LAEC) 的标准治疗方法.
- 接受NAC的老年人 (≥65岁) 可能会在体力活动水平上出现显著变化.
- 了解影响NAC期间久坐时间的因素对于管理老年患者至关重要.
研究的目的:
- 调查导致老年LAEC患者接受NAC.坐姿时间增加的因素.
- 探索在NAC期间增加的久坐行为背后的潜在临床机制.
- 评估NAC对老年LAEC患者静坐时间的影响.
主要方法:
- 一项前性队列研究,涉及69名老年患者 (≥65岁) 患有LAEC,接受NAC.
- 静坐时间用全球体力活动问卷测量在NAC之前和之后.
- 多变量回归分析以确定与静止时间变化相关的因素.
主要成果:
- 在NAC期间,平均静坐时间增加了322分钟/周.
- 疲劳恶化是与久坐时间增加相关的重要因素 (p=0.015).
- 化疗方案包括多塞塔克塞尔,西斯,甲和氧沙的组合.
结论:
- 在老年LAEC患者中,NAC期间的久坐时间增加与疲劳恶化有关.
- 在NAC期间的体力活动干预措施可能会提高这个患者群体的临床结果.
- 对老年癌症患者来说,需要对疲劳管理和身体活动进行进一步的研究.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
738
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
738
Esophageal Strictures-II: Clinical Features and Management
392
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
392
Gastric Emptying
3.2K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.2K
Esophageal Varices-II: Clinical Features and Management
340
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
340
Esophagus
3.6K
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
3.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
567
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
567


